Serum Concentrations of Some Neuroactive Steroids in Women Suffering from Mixed Anxiety-Depressive Disorder
Tóm tắt
Từ khóa
Tài liệu tham khảo
Robel, P. and Baulieu, E. E. 1994. Neurosteroids-Biosynthesis and Function. Pages 36–50, in De Kloet, E. R., and Sutanto, W.(eds.), Neurobiology of Steroids, Acad. Press, San Diego.
Paul, S. M. and Purdy, R. H. 1992. Neuroactive steroids. FASEB J. 6:2311–2322.
Wang, M., Seippel, L., Purdy, R. H., and Bä ckströ m, T. 1996. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregenenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J. Clin. Endocrinol. Metab. 81:1076–1082.
MacDonald, P. C., Dombroski, R. A., and Casey, M. L. 1991. Recurrent secretion of progesterone in large amounts: an endocrine/metabolic disorder unique to young women? Endoc. Rev. 12:372–401.
Freeman, E. W., Purdy, R. H., Coutifaris, C., Rickels, K., and Paul, S. M. 1993. Anxiolytic metabolites of progesterone: mood and performance measures following oral progesterone administration to healthy female volunteers. Clin. Neuroendocrinol. 58:478–484.
Bičíková , M., Dibbelt, L., Hill, M., Hampl, R., and Stárka, L. 1998. Allopregnanolone in women with premenstrual syndrome. Horm. Metab. Res. 30:227–230.
Sundströ m, I., Andersson, A., Nyberg, S., Purdy, R. H., and Bä ckströ m, T. 1998. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Clin. Neuroendocrinol. 67:126–138.
Monteleone, P., Luisi, S., Tonetti, A., Bernardi, F., Genazzani, A. D., Luisi, M., Petraglia, F., and Genazzani, A. R. 2000. Allopregnanolone concentrations and premenstrual syndrome. Eur. J. Endocrinol. 142:269–273.
Kaplan, H. I. and Sadock, B. J. 1995. Comprehensive Textbook of Psychiatry, 6th edition, Williams & Wilkins, Baltimore.
Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., and Rupprecht, R. 1998. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 155:910–913.
Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., and Guidotti, A. 1998. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Nat. Acad. Sc.i USA 95:3239–3244.
Guidotti, A. and Costa, E. 1998. Can antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol. Psychiatry 44:865–873.
Sheline, Y., Bardgett, M. E., and Csernansky, J. G. 1997. Correlated reduction in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. J. Clin. Psychopharmacol. 17:11–14.
Hiemke, C., Banger, M., Knuppen, R., Haupt, O., and Jussofie, A. 1991. Production of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in man. J. Neurology 3:261–265.
Bičíková , M., Lapčí k, O., Hampl, R., Stárka, L., Knuppen, R., Haupt, O., and Dibbelt, L. 1995. A novel radioimmunoassay of allopregnanolone. Steroids 60:210–213.
Hill, M., Lukáč, D., Lapčí k, O., Šulcová , J., Hampl, R., Pouzar, V., and Stárka, L. 1999. Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in normal subjects. Clin. Chem. Lab. Med. 37:439–447.
Uzunov, D. P., Cooper, T. B., Costa E., and Guidotti A. 1996. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Nat. Acad. Sci. USA 93:12599–12604.
Griffin, L. D. and Mellon, S. H. 1999. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Nat. Acad. Sci. USA 96:13512–13517.
Baulieu, E. E. 1997. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52:1–32.
Robel, P. and Baulieu, E. E. 1995. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Dehydroepiandrosterone (DHEA) and aging. Ann. N.Y. Acad. Sci. 774:82–110.
Wang, M., Wahlströ m, G., and Bä ckströ m, T. 1997. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J. Steroid Biochem. Molec. Biol. 62:299–306.
Aso, T. 1976. A radioimmunoassay method for simultaneous determination of pregnenolone, pregnenolone sulfate, dehydroepiandrosterone and dehydroepiandrosterone sulfate in human plasma. Nippon Niabunpi Gakkai Zasshi 52:1008–1019.
De Peretti, E. and Mappus, E. 1983. Pattern of plasma pregnenolone sulfate levels in humans from birth to adulthood. J. Clin. Endocrinol. Metab. 57:550–556.
Hedman, M., Nilsson, E., and de la Torre, B. 1989. Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus (SLE). Clin. Exper. Rheumatol. 7:583–588.